These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 31801326)

  • 21. [The features of postprandial glucose state in type 2 diabetes mellitus].
    Zhou J; Jia WP; Yu M; Ma XJ; Bao YQ; Lu W
    Zhonghua Yi Xue Za Zhi; 2006 Apr; 86(14):970-5. PubMed ID: 16759538
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The effect of high- and low-glycemic index energy restricted diets on plasma lipid and glucose profiles in type 2 diabetic subjects with varying glycemic control.
    Heilbronn LK; Noakes M; Clifton PM
    J Am Coll Nutr; 2002 Apr; 21(2):120-7. PubMed ID: 11999539
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [The overweight, the obesity and the glycemic control among diabetics of the provincial reference center of diabetes (CRD), Kenitra, Morocco].
    Lotfi Z; Aboussaleh Y; Sbaibi R; Achouri I; Benguedour R
    Pan Afr Med J; 2017; 27():189. PubMed ID: 28904714
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Correlation between 1,5-anhydroglucitol and glycemic excursions in type 2 diabetic patients.
    Sun J; Dou JT; Wang XL; Yang GQ; Lü ZH; Zheng H; Ma FL; Lu JM; Mu YM
    Chin Med J (Engl); 2011 Nov; 124(22):3641-5. PubMed ID: 22340217
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Orlistat in the treatment of overweight or obese Chinese patients with newly diagnosed Type 2 diabetes.
    Shi YF; Pan CY; Hill J; Gao Y
    Diabet Med; 2005 Dec; 22(12):1737-43. PubMed ID: 16401321
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Long-term effects of a lifestyle intervention on weight and cardiovascular risk factors in individuals with type 2 diabetes mellitus: four-year results of the Look AHEAD trial.
    ; Wing RR
    Arch Intern Med; 2010 Sep; 170(17):1566-75. PubMed ID: 20876408
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of dietary and physical activity interventions on the risk of type 2 diabetes in South Asians: meta-analysis of individual participant data from randomised controlled trials.
    Jenum AK; Brekke I; Mdala I; Muilwijk M; Ramachandran A; Kjøllesdal M; Andersen E; Richardsen KR; Douglas A; Cezard G; Sheikh A; Celis-Morales CA; Gill JMR; Sattar N; Bhopal RS; Beune E; Stronks K; Vandvik PO; van Valkengoed IGM
    Diabetologia; 2019 Aug; 62(8):1337-1348. PubMed ID: 31201437
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Results of the glucose-lowering effect of WelChol study (GLOWS): a randomized, double-blind, placebo-controlled pilot study evaluating the effect of colesevelam hydrochloride on glycemic control in subjects with type 2 diabetes.
    Zieve FJ; Kalin MF; Schwartz SL; Jones MR; Bailey WL
    Clin Ther; 2007 Jan; 29(1):74-83. PubMed ID: 17379048
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of Acarbose on Glycemic Variability in Patients with Poorly Controlled Type 2 Diabetes Mellitus Receiving Stable Background Therapy: A Placebo-Controlled Trial.
    Derosa G; Franzetti I; Querci F; D'Angelo A; Maffioli P
    Pharmacotherapy; 2015 Nov; 35(11):983-90. PubMed ID: 26598090
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A Behavioral Lifestyle Intervention Enhanced With Multiple-Behavior Self-Monitoring Using Mobile and Connected Tools for Underserved Individuals With Type 2 Diabetes and Comorbid Overweight or Obesity: Pilot Comparative Effectiveness Trial.
    Wang J; Cai C; Padhye N; Orlander P; Zare M
    JMIR Mhealth Uhealth; 2018 Apr; 6(4):e92. PubMed ID: 29636320
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of reducing free sugars on 24-hour glucose profiles and glycemic variability in subjects without diabetes.
    Pappe CL; Peters B; Dommisch H; Woelber JP; Pivovarova-Ramich O
    Front Nutr; 2023; 10():1213661. PubMed ID: 37850088
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Impact of flash glucose monitoring on hypoglycaemia in adults with type 1 diabetes managed with multiple daily injection therapy: a pre-specified subgroup analysis of the IMPACT randomised controlled trial.
    Oskarsson P; Antuna R; Geelhoed-Duijvestijn P; Krӧger J; Weitgasser R; Bolinder J
    Diabetologia; 2018 Mar; 61(3):539-550. PubMed ID: 29273897
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A randomized clinical trial comparing low-fat with precision nutrition-based diets for weight loss: impact on glycemic variability and HbA1c.
    Kharmats AY; Popp C; Hu L; Berube L; Curran M; Wang C; Pompeii ML; Li H; Bergman M; St-Jules DE; Segal E; Schoenthaler A; Williams N; Schmidt AM; Barua S; Sevick MA
    Am J Clin Nutr; 2023 Aug; 118(2):443-451. PubMed ID: 37236549
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of Metformin Added to Insulin on Glycemic Control Among Overweight/Obese Adolescents With Type 1 Diabetes: A Randomized Clinical Trial.
    Libman IM; Miller KM; DiMeglio LA; Bethin KE; Katz ML; Shah A; Simmons JH; Haller MJ; Raman S; Tamborlane WV; Coffey JK; Saenz AM; Beck RW; Nadeau KJ;
    JAMA; 2015 Dec; 314(21):2241-50. PubMed ID: 26624824
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Liraglutide narrows the range of circadian glycemic variations in Japanese type 2 diabetes patients and nearly flattens these variations in drug-naive type 2 diabetes patients: a continuous glucose monitoring-based study.
    Mori Y; Taniguchi Y; Sezaki K; Yokoyama J; Utsunomiya K
    Diabetes Technol Ther; 2011 Nov; 13(11):1139-44. PubMed ID: 21877924
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The effect of medical nutrition therapy by a registered dietitian nutritionist in patients with prediabetes participating in a randomized controlled clinical research trial.
    Parker AR; Byham-Gray L; Denmark R; Winkle PJ
    J Acad Nutr Diet; 2014 Nov; 114(11):1739-48. PubMed ID: 25218597
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pharmacokinetic, pharmacodynamic, and tolerability profiles of the dipeptidyl peptidase-4 inhibitor linagliptin: a 4-week multicenter, randomized, double-blind, placebo-controlled phase IIa study in Japanese type 2 diabetes patients.
    Horie Y; Kanada S; Watada H; Sarashina A; Taniguchi A; Hayashi N; Graefe-Mody EU; Woerle HJ; Dugi KA
    Clin Ther; 2011 Jul; 33(7):973-89. PubMed ID: 21723606
    [TBL] [Abstract][Full Text] [Related]  

  • 38. An integrated intervention program to control diabetes in overweight Chinese women and men with type 2 diabetes.
    Sun J; Wang Y; Chen X; Chen Y; Feng Y; Zhang X; Pan Y; Hu T; Xu J; Du L; Zhou W; Zhao H; Riley RE; Mustad VA
    Asia Pac J Clin Nutr; 2008; 17(3):514-24. PubMed ID: 18818173
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Use of sibutramine in overweight adult hispanic patients with type 2 diabetes mellitus: a 12-month, randomized, double-blind, placebo-controlled clinical trial.
    Sánchez-Reyes L; Fanghänel G; Yamamoto J; Martínez-Rivas L; Campos-Franco E; Berber A
    Clin Ther; 2004 Sep; 26(9):1427-35. PubMed ID: 15531005
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.